Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Not Yet Recruiting

Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine

NCT07563023

Conditions: HIV Associated Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study

NCT07558057

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details

Not Yet Recruiting

Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors

NCT07539610

Conditions: B Acute Lymphoblastic Leukemia/Lymphoma, B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
Locations: Institute of Hematology, Chinese Academy of Medical Sciences & Hospital of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment

NCT07476105

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B, Hemic and Lymphatic Diseases, +10 more
Locations: Azienda Ospedaliero Universitaria delle Marche - S.O.D. Clinica Ematologica Ancona, Italy

A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy

I.R.C.C.S. Centro di Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati Aviano, Italy

I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy

View all 24 locations

View Trial Details

Not Yet Recruiting

A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

NCT07476378

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL), Disease Attributes, +22 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Langfang, Hebei, China

View Trial Details

Not Yet Recruiting

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

NCT07476729

Conditions: B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: St. Anna Kinderspital GmbH Vienna, Austria

Ghent University Hospital Ghent, Belgium

Fakultni Nemocnice V Motole Prague, Czechia

Rigshospitalet Copenhagen, Denmark

View all 20 locations

View Trial Details

Not Yet Recruiting

Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

NCT07463781

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High Grade B Cell Lymphoma, +11 more
Locations: SCDU Ematologia - AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria Alessandria, Italy

Clinica di Ematologia, AOU Ospedali Riuniti Ancona, Italy

USD-TMO Adulti - ASST Spedali Civili di Brescia Brescia, Italy

Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello Palermo, Italy

View Trial Details

Not Yet Recruiting

This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R

NCT07412405

Conditions: Adult B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +31 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study

NCT07398638

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy

NCT07310186

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions